In long-time users of telomerase activators, I tend to see a narrowing of the histogram which is great news as long as the progenitors are numerous and healthy. This means are less “crew cut” and “dreadlock” telomeres and that the system is rebalancing and lengthening the telomere efficiently.
Check out this recent PODCAST I did about spinal cord injury. I explain the clinical aspects, why treatment is difficult, whether stem cell treatments are helpful, and we talk to Porter and his wife about his remarkable journey back to walking at the age of 73.
When data from the Copehnhagen City Heart Study was published in 2013, they concluded that shorter telomeres in leukocytes was not associated with increased cancer after adjusting for age but that it WAS associated with reduced survival from cancer http://jnci.oxfordjournals.org/content/105/7/459.long
In 2015, the same data looked at certain gene tendencies that promote telomere shortening and concluded that cancer survival was IMPROVED when shortening was enhanced in the telomeres.
Contradiction? Not so fast.
The moral of the story, think outside the box if you want to stay there. She should have had the primary removed but couldn’t find a maverick surgeon to take it out even after she had cleared metastases to the brain and spine.
So I guess I’ll just have to sit here like Leif Ericson in New England until other Columbi (plural of Columbus?) decide to plant their flag on this wonderful new world of common sense and scientifically-backed conclusions.
In this brief segment from 2010, CBS news interviewed me about TA-65 a year after the Nobel Prize in Medicine was awarded for the discovery of telomerase, the substance that TA-65 “activates” and that keeps your stem cells from becoming damaged.
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
